Evaluation of the Efficacy and Safety of Desvenlafaxine 50 and 100 mg/d in Patients With Major Depressive Disorder: Results From 2 Placebo-Controlled Studies
- Jim Meaney, Wyeth Research, Collegeville, Pennsylvania, United States
|
A Pooled Analysis of the Effects of Desvenlafaxine Succinate on Symptoms of Anxiety in Patients with Major Depressive Disorder
- Jim Meaney, Wyeth Research, Collegeville, Pennsylvania, United States
|
Assessing Depression in Acute Coronary Syndrome Patients
- Thomas Mclaughlin, UMASS MEDICAL SCHOOL, United States
|
The Kava Anxiety Depression Spectrum Study (KADSS): A randomized, placebo-controlled, cross-over trial using an aqueous extract of Piper methysticum
- Jerome Sarris, The University of Queensland, Australia
|